Adlai Nortye opens Boston Innovation Centre

Pharma |  News | 0 Comment | 20 Aug, 2018

Adlai Nortye, a Hangzhou biopharma, has announced the opening of its first US site in Boston, Massachusetts. The Boston site was opened by CEO Carsten Lu, CDO Dr. Lars E. Bigerson, M.D., Ph...Read more

BiondVax relocates to new manufacturing facility

Pharma |  News | 0 Comment | 20 Aug, 2018

BiondVax Pharmaceuticals Ltd., developer of the M-001 universal influenza vaccine candidate, recently reported the company's relocation to a newly constructed mid-size commercial scale manu...Read more

Health Canada approves Daewoong’s BTX

Pharma |  News | 0 Comment | 20 Aug, 2018

Daewoong Pharmaceutical has received sales approval for Nabota, its botulinum toxin (BTX) product to treat forehead wrinkles, from Health Canada. Nabota became the first product initially ...Read more

Eisai, Merck get FDA approval for LENVIMA capsules to treat HCC

Pharma |  News | 0 Comment | 17 Aug, 2018

Eisai Inc. and Merck known as MSD outside of the United States and Canada, announced the U.S. Food and Drug Administration (FDA) approved the kinase inhibitor LENVIMA® (lenvatinib) for ...Read more

Bugworks Research raises $9M in series A funding

Pharma |  News | 0 Comment | 16 Aug, 2018

Bangalore India and Delaware, USA, based biopharma startup Bugworks Research, designing first-in-class antibiotics announced the completion of a $9M Series-A financ...Read more

rfxcel enhances Pharmaceutical Track and Trace Solution for Russia

Pharma |  News | 0 Comment | 16 Aug, 2018

rfxcel, the global leader in track and trace solutions, releases enhancements to its compliance solution for Russia and kicks off additional customer implementations in the Russian marketpl...Read more

Middle East, Africa pharma economy to reach $38.8B by 2021

Pharma |  News | 0 Comment | 16 Aug, 2018

CPhI MEA (Middle East and Africa) launches next month as favourable market conditions are driving increased growth across the Middle East and North Africa (MENA) pharma market – agein...Read more

Mylan brings first generic for Adcirca tablets

Pharma |  News | 0 Comment | 14 Aug, 2018

Global pharmaceutical company Mylan N.V.  has announced the U.S. launch of Tadalafil Tablets USP, 20 mg, the first generic version of the reference listed drug, Eli Lilly and Comp...Read more

Haisco to make $10M equity investment in Pneuma Respiratory

Pharma |  News | 0 Comment | 14 Aug, 2018

Haisco Pharmaceutical Group Co Ltd, a China-based company focused on the research and development and marketing of therapeutic drugs, has agreed to make a $10 million equity investment in P...Read more

PharmaLytica 2018 highlights Quality Culture and Regulatory Compliance trends of the Pharma Sector

Pharma |  News | 0 Comment | 13 Aug, 2018

UBM India, the organisers of CPhI / P-MEC India, the leading global pharma trade show and conference, recently hosted the 5th edition of PharmaLytica 2018 in Hyderabad at the HITEX Exhibiti...Read more

Synergy Pharmaceuticals inks deal with Luxion Pharma

Pharma |  News | 0 Comment | 10 Aug, 2018

Synergy Pharmaceuticals  recently announced that the company has entered into a license agreement with Luoxin Pharmaceutical Group, Shandong  providing Luoxin with exclusive right...Read more

Star Combo Pharma acquires Ausway Group of Companies

Pharma |  News | 0 Comment | 10 Aug, 2018

Star Combo Pharma recently announced that it has signed a Heads of Agreement to acquire the Ausway Group of companies (Ausway) being, Ausway Pharmaceutical Pty Ltd, Austoyou ...Read more

Astellas acquires Quethera for up to £85M

Pharma |  News | 0 Comment | 10 Aug, 2018

Singapore- Astellas Pharma and Quethera Limited announced that Astellas has acquired Quethera, a gene therapy company headquartered in the United Kingdom, that is focused on developing...Read more

Australia gives its nod to Trastuzumab Biosimilar

Pharma |  News | 0 Comment | 09 Aug, 2018

Australia’s Therapeutic Goods Administration (TAG) has approved Celltrion’s Herzuma, the country’s first biosimilar trastuzumab. While Celltrion is in discussions with af...Read more

WHO HCV Guidelines recommends Ascletis' Ravidasvir

Pharma |  News | 0 Comment | 09 Aug, 2018

Ascletis Pharma Inc  announced  Ravidasvir is recommended by the World Health Organization (WHO) Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepat...Read more

FDA gives nod to treat rare non-Hodgkin lymphoma

Pharma |  News | 0 Comment | 09 Aug, 2018

The U.S. Food and Drug Administration  approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for the treatment of adult patients with relapsed or refractory mycosis fun...Read more

Eisai inks deal with Taiwan's CY Biotech

Pharma |  News | 0 Comment | 08 Aug, 2018

Japan-based Eisai recently announced that it has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride (generic n...Read more

I-Mab Biopharma, MorphoSys declares China IND Submission of monoclonal antibody

Pharma |  News | 0 Comment | 08 Aug, 2018

On August 8, 2018, Beijing time I-Mab Biopharma ("I-Mab"), a Shanghai-based biotech company focused on innovative biologics in oncology and autoimmune disease, and German biopharma company ...Read more